Related Experiment Video
Updated: Jul 13, 2026
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread
Shun-ichi Watanabe1, Hisao Asamura, Kenji Suzuki
1Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan. syuwatan@ncc.go.jp
Abstract:
A new strategy for selective nodal dissection in non-small cell lung cancer (NSCLC) patients according to the segment of primary tumor was explored. Data on 504 patients with NSCLC of less than 5 cm, histologically revealed to be N2 disease after thoracotomy, were analyzed. In right upper lobe (RUL) tumor, when the pretracheal node was negative, the incidence of subcarinal involvement was 3.8%. In lower lobe tumor, superior segment (RLL-Superior and LLL-Superior) tumor showed a significantly higher incidence of superior mediastinal involvement than basal segment (RLL-Basal and LLL-Basal) tumor (right, P=0.0036; left, P=0.0499). When the subcarinal node was negative, the incidence of superior mediastinal metastasis in RLL-basal and LLL-Basal tumor was 11% and 8%, respectively. In left upper lobe tumor, superior segment (LUL-Superior) tumor showed a significantly lower incidence of subcarinal involvement than lingular segment (LUL-Lingular) tumor (P=0.0381). When aortic nodes were negative in LUL-Superior tumor, the incidence of subcarinal metastasis was 6%. Collectively, in RUL and LUL-Superior tumors, subcarinal dissection may be unnecessary if superior mediastinal node is negative. In RLL-Superior and LLL-Superior tumors, extensive dissection is required. In RLL-Basal and LLL-Basal tumors, superior mediastinal dissection may be unnecessary if subcarinal node is negative.
Insights
Selective nodal dissection for non-small cell lung cancer (NSCLC) can be guided by primary tumor location. This strategy helps determine which lymph nodes require dissection, potentially optimizing treatment for NSCLC patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Accurate lymph node staging is crucial for non-small cell lung cancer (NSCLC) treatment planning.
- Current nodal dissection strategies may not fully account for primary tumor location's impact on metastasis patterns.
- Identifying selective nodal dissection criteria can improve surgical decision-making and patient outcomes.
Purpose of the Study:
- To explore a novel strategy for selective nodal dissection in NSCLC based on the primary tumor's segmental location.
- To analyze the correlation between primary tumor location and the incidence of mediastinal lymph node involvement.
- To refine surgical guidelines for mediastinal lymphadenectomy in NSCLC.
Main Methods:
- Retrospective analysis of data from 504 NSCLC patients with N2 disease confirmed after thoracotomy.
- Patients had primary tumors less than 5 cm in size.
- Analysis focused on lymph node involvement patterns (pretracheal, subcarinal, superior mediastinal, aortic) relative to primary tumor location (e.g., RUL, LUL-Superior, LLL-Basal).
Main Results:
- Right upper lobe (RUL) tumors: Low subcarinal involvement (3.8%) when pretracheal nodes are negative.
- Lower lobe tumors: Superior segments showed higher superior mediastinal involvement than basal segments (P<0.05). Basal segments had 11% (right) and 8% (left) superior mediastinal metastasis when subcarinal nodes were negative.
- Left upper lobe (LUL) tumors: LUL-Superior tumors had lower subcarinal involvement than lingular segments (P=0.0381). Subcarinal metastasis was 6% in LUL-Superior tumors when aortic nodes were negative.
Conclusions:
- Selective nodal dissection is feasible in NSCLC, guided by primary tumor location.
- For RUL and LUL-Superior tumors, subcarinal dissection may be omitted if superior mediastinal nodes are negative.
- Extensive dissection is recommended for RLL-Superior and LLL-Superior tumors; superior mediastinal dissection may be unnecessary for RLL-Basal and LLL-Basal tumors if subcarinal nodes are negative.
